UPDATE 2-Novartis to supply Zelnorm for U.S. restricted use

(Reuters) - ZURICH, July 27 - Swiss drugmaker Novartis
said on Friday it would make bowel drug Zelnorm
available to U.S. patients on a restricted basis after pulling
the product from the market at the request of regulators.




Novartis said it had established a restricted access
programme for Zelnorm in cooperation with U.S. regulators so
that patients in need of the drug can be considered for
treatment.


Read more at Reuters.com Government Filings News